201. Angelman syndrome
19 clinical trials,   30 drugs   (DrugBank: 7 drugs),   22 drug target genes,   20 drug target pathways
Searched query = "Angelman syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00348933 (ClinicalTrials.gov) | July 2006 | 3/7/2006 | Dietary Supplements for the Treatment of Angelman Syndrome | Efficacy of a Therapeutic Treatment Trial in Angelman Syndrome | Angelman Syndrome;Nervous System Diseases | Drug: Betaine;Drug: Creatine;Drug: Metafolin;Drug: Vitamin B12 | University of California, San Diego | Baylor College of Medicine;Rady Children's Hospital, San Diego;Boston Children’s Hospital;Greenwood Genetic Center;Rare Diseases Clinical Research Network | Completed | N/A | 5 Years | All | 90 | N/A | United States |